|
Re: Looks like 0 participation in warrant incentive imo - answer to my email...
|
3
|
Resverlogix Corp.
|
Jan 27, 2020 12:09PM
|
|
Long Term Share Price Trend
|
3
|
Resverlogix Corp.
|
Jul 31, 2024 10:21AM
|
|
Re: Zenith Epigenetics Announces Clinical Trial Collaboration with Pfizer
|
3
|
Zenith Epigenetics
|
Nov 21, 2018 03:32PM
|
|
Advice
|
3
|
Resverlogix Corp.
|
Nov 19, 2021 11:50AM
|
|
Re: Zenith Epigenetics Announces U.S. FDA Clearance of Investigational New Drug Application for ZEN-3694 in TNBC Program
|
3
|
Zenith Epigenetics
|
Mar 21, 2019 03:07PM
|
|
Re: AGM
|
3
|
Resverlogix Corp.
|
Nov 21, 2020 10:07AM
|
|
Re: New exempt distribution
|
3
|
Resverlogix Corp.
|
May 06, 2021 11:39AM
|
|
Re: The European Medicines Agency (EMA)...
|
3
|
Resverlogix Corp.
|
Jun 23, 2015 06:35PM
|
|
Re: RVX Long Covid Trial
|
3
|
Resverlogix Corp.
|
May 27, 2023 09:57AM
|
|
Re: TSX Review
|
3
|
Resverlogix Corp.
|
Mar 15, 2018 01:18PM
|
|
Re: Sabizabulin - mCRPC- used now for Covid 19.
|
3
|
Zenith Epigenetics
|
Apr 14, 2022 01:12PM
|
|
Re: ZEN003694 Trial Now Listed on ClinicalTrials.gov
|
3
|
Zenith Epigenetics
|
Mar 15, 2016 06:56PM
|
|
Re: Vote reminder
|
3
|
Zenith Epigenetics
|
Oct 23, 2023 11:05AM
|
|
Re: Timing is everything !!!
|
3
|
Resverlogix Corp.
|
Feb 25, 2016 04:52PM
|
|
Re: Not quite a breakout yet....
|
3
|
Resverlogix Corp.
|
Apr 20, 2019 02:32PM
|
|
Re: My Rant - Limited attendance AGM, one way communication, vetted questions
|
3
|
Resverlogix Corp.
|
Jun 21, 2022 10:41AM
|
|
Re: New blog entry: Disrupting Treatment of Cardiovascular Disease with Epigenetics
|
3
|
Resverlogix Corp.
|
Aug 27, 2015 10:47AM
|
|
Re: BETonMACE Enrollment
|
3
|
Resverlogix Corp.
|
Sep 02, 2017 02:06PM
|
|
Re: Zenith NYAS Symposium notes
|
3
|
Zenith Epigenetics
|
Apr 29, 2016 06:56PM
|
|
Re: AGM - Jan 7, 2016 - Details
|
3
|
Zenith Epigenetics
|
Jan 13, 2016 05:08PM
|
